Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/1991
12/03/1991US5070021 Method of modifying oligosaccharide structure of tissue plasminogen activator
12/03/1991US5070013 Immunochemical assay for human granulocyte-macrophage colony stimulating factor
12/03/1991US5069901 Deactivated antigens
12/03/1991US5069896 Malodor inhibiting skin deodorant composition comprising a monoclonal antibody and method of deodorizing
12/03/1991CA1292708C Monoclonal antibody against plasminogen-activating factor
12/02/1991WO1991019000A1 A MONOCLONAL ANTIBODY AGAINST THE GAG PROTEIN PRECURSOR p55 OF HUMAN IMMUNODEFICIENCY VIRUS
12/02/1991CA2083399A1 Monoclonal antibody against the gag protein precursor p55 of human immunodeficiency virus
12/02/1991CA2043620A1 Microbially expressed portions of a monoclonal antibody block rhinovirus attachment to cell receptors
12/02/1991CA2043565A1 Enzyme and dna coding therefor
12/02/1991CA2043535A1 Hybridoma and production of biologically active substance
12/01/1991WO1991018919A1 Purification of human interleukin-4 from a secreted escherichia coli mutant
11/1991
11/30/1991CA2064710A1 Recombinant protein which binds to a complex viral antigen of hiv-1
11/30/1991CA2043378A1 Process for reduction of certain cyclohexapeptide compounds
11/30/1991CA2043372A1 Phencyclidine and phencyclidine metabolites assay, tracers, immunogens, antibodies and reagent kit
11/30/1991CA2043049A1 Precursor forms of procine growth hormone releasing factor and related dna compounds
11/30/1991CA2041415A1 Monoclonal antibodies which bind mevalonate kinase
11/28/1991WO1991018293A1 Monoclonal antibodies specific for toxin b of clostridium difficile
11/28/1991WO1991018106A1 Modified antibodies
11/28/1991WO1991018098A1 Bone and cartilage inductive proteins
11/28/1991WO1991018097A1 Cd46 variants
11/28/1991WO1991018015A1 Alveolar surfactant proteins
11/28/1991WO1991018010A1 Inhibition of viral infection using intercellular adhesion molecule-1-like peptides and/or analogues thereof
11/28/1991WO1991017773A2 New protein-polycation conjugates
11/28/1991WO1991017770A1 Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy
11/28/1991WO1991017765A1 Fibrin binding domain polypeptides and uses and methods of producing same
11/28/1991WO1991017669A1 Production of a proteinaceous composition
11/28/1991WO1991008478A3 METHODS OF DETECTING COLLAGEN DEGRADATION $i(IN VIVO)
11/28/1991CA2083391A1 Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy
11/28/1991CA2082941A1 Bone and cartilage inductive proteins
11/28/1991CA2082277A1 Cd46 variants
11/28/1991CA2063709A1 Monoclonal antibodies specific for toxin b of clostridium difficile
11/27/1991EP0458475A2 Transpeptidation reagent and method
11/27/1991EP0458437A1 Process for production of human nerve growth factor by genetic engineering
11/27/1991EP0458072A1 Immunologic enhancement of the somatogenic effect of somatotropin with an antibody
11/27/1991EP0457875A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
11/27/1991EP0457766A1 Drosophila receptors homologous to mammalian steroid receptors
11/27/1991CN1056427A Gene therapy for cell proliferative diseases
11/27/1991CN1014903B Method for producing interferons
11/26/1991WO1991018921A1 GROWTH FACTOR WHICH INHIBITS THE GROWTH OF CELLS OVEREXPRESSING THE HUMAN ONCOGENE erbB-2
11/26/1991WO1991018618A2 Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection
11/26/1991US5068192 Attenuated pseudorabies virus which includes foreign DNA encoding an amino acid sequence
11/26/1991US5068191 Purified histo-blood group a glycosyltransferase and antibodies thereto
11/26/1991CA2083688A1 Growth factor which inhibits the growth of cells overexpressing the human oncogene erbb-2
11/26/1991CA2062758A1 Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection
11/25/1991WO1991018047A2 Mammalian expression of the bmp-2 family
11/25/1991CA2082052A1 Mammalian expression of the bmp-2 family
11/24/1991WO1991018107A1 Measuring non-dystrophin proteins and diagnosing muscular dystrophy
11/24/1991CA2083598A1 Measuring non-dystrophin proteins and diagnosing muscular dystrophy
11/23/1991WO1991017769A1 Novel methods for producing antigen-specific, high-affinity human monoclonal antibodies
11/23/1991CA2082041A1 Methods for producing antigen-specific, high-affinity human monoclonal antibodies
11/21/1991EP0457685A1 New mycoplasmas-means for detecting and characterising mycoplasmas in vitro
11/21/1991EP0457532A1 Monoclonal antibody which inhibits the biological action of platelet factor 4
11/21/1991EP0457527A1 Plasmids, transformed animal cells and process for producing foreign protein
11/21/1991EP0457250A2 Novel bifunctional linking compounds, conjugates and methods for their production
11/21/1991EP0456766A1 TYPE oc PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE
11/21/1991EP0456727A1 Monoclonal antibodies directed against vitronectin and fibronectin, and uses thereof
11/21/1991EP0456719A1 Anti-idiotype antibodies reactive with shared idiotopes expressed by human lymphomas and autoantibodies
11/21/1991EP0456662A1 Vaccine for the preventative treatment of infection of liver fluke in ruminants
11/21/1991EP0456642A1 Somatotropin analogs
11/21/1991EP0456640A1 Genetically engineered endothelial cells and use thereof
11/20/1991CN1056245A Bcrf1 antagonists for treating epstein-barr virus infections
11/19/1991WO1991018112A1 Novel mycoplasmas and devices for detecting and characterizing mycoplasmas in vitro
11/19/1991CA2083267A1 Mycoplasma - in vitro mycoplasma detection and caracterization methods
11/19/1991CA1292200C Method for producing protein containing nonprotein amino acids
11/19/1991CA1292197C Method for stabilizing extra-chromosomal elements in bacteria during cultivation
11/18/1991WO1991018096A1 Methods for trans-destabilization of specific proteins in vivo
11/18/1991WO1991018001A1 Trans-dominant suppressor genes for oligomeric proteins
11/18/1991CA2083164A1 Trans-dominant suppressor genes for oligomeric proteins
11/17/1991WO1991017764A1 Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding
11/16/1991WO1991018102A1 Shuttle vector for recombinant bacillus thuringiensis strain development
11/16/1991WO1991018019A1 Soluble single chain t cell receptors
11/16/1991CA2047733A1 Soluble single chain t cell receptors
11/16/1991CA2042437A1 Immunologic enhancement of the somatogenic effect of somatotrophin with an antibody
11/15/1991WO1991018099A1 Target-specific, cytotoxic, recombinant pseudomonas exotoxin
11/15/1991CA2042005A1 Plasmids, transformed animal cells and process for producing foreign protein
11/14/1991WO1991017271A1 Recombinant library screening methods
11/14/1991WO1991017253A1 Mammalian cells expressing a hybrid receptor
11/14/1991WO1991017249A1 Interleukin-1 antagonist and uses thereof
11/14/1991WO1991017248A1 Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy
11/14/1991WO1991017188A1 Separation of mammalian semen into fractions enriched either for spermatozoa containing an x chromosome or for spermatozoa contai ning a y chromosome
11/14/1991WO1991017179A1 Peptide analogs to proteins of the immunoglobulin superfamily
11/14/1991WO1991017174A1 Dna encoding human 5-ht1d receptors and uses thereof
11/14/1991WO1991016925A1 Specific dna sequences related to an ibdv protein including vectors, hosts and vaccines
11/14/1991WO1991016922A1 Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity
11/14/1991WO1991012023A3 Hybrid reagents capable of selectively releasing molecules into cells
11/14/1991DE4014510A1 Variante cd44-oberflaechenproteine, diese kodierende c-dna-sequenzen, antikoerper gegen diese proteine sowie ihre verwendung in der diagnostik und therapie Variant CD44-oberflaechenproteine, this encoding c-dna sequences, antibodies against these proteins and their use in the diagnosis and therapy
11/14/1991CA2374571A1 Dna encoding human 5-ht1d receptors and uses thereof
11/14/1991CA2081774A1 Interleukin-1 antagonist and uses thereof
11/13/1991EP0456507A2 Heterologous promoter systems
11/13/1991EP0456332A1 Purified interleukin 1 and DNA coding for interleukin 1 and their preparation, vectors containing such DNA and their preparation and use in transforming hosts to permit expression of interleukin 1
11/13/1991EP0456215A1 Monoclonal antibodies to pres2 and pres1 polypeptides of the hepatitis B viral envelope
11/13/1991EP0456200A1 Mutein of granulocyte colony stimulating factor (G-CSF)
11/13/1991EP0456197A1 Seroreactive epitopes from proteins of human papilloma virus (HPV) 18
11/13/1991EP0456138A2 Peptide-amidase and its application
11/13/1991EP0455741A1 Method for detecting inhibitors of tat protein
11/13/1991EP0455722A1 Processes for producing polypeptide inhibitors of platelet activation and methods, combinations and compositions using them
11/13/1991EP0455707A1 BLOOD-COAGULATION FACTOR XIIa -g(b) MONOCLONAL ANTIBODY AND IMMUNOASSAY.
11/13/1991EP0455682A1 Polypeptides having a human beta-adrenergic receptor activity, and playing a role in lipolytic response, nucleic acids coding for these polypeptides and use of said polypeptides for screening substances which act on these polypeptides.
11/13/1991EP0455665A1 Hybrid seed production
11/13/1991EP0236385B1 A superoxide dismutase
1 ... 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 ... 1125